{"id":61155,"date":"2024-10-31T00:04:58","date_gmt":"2024-10-31T00:04:58","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/31\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/"},"modified":"2024-10-31T00:04:58","modified_gmt":"2024-10-31T00:04:58","slug":"ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/","title":{"rendered":"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET"},"content":{"rendered":"<div>\n<p>PRINCETON, N.J., Oct.  30, 2024  (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to the market open.<\/p>\n<p>Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, and Chris Mutz, Head of Rare Disease, will host a conference call to discuss the results as follows:<\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:20%; width:20%; min-width:20%;;vertical-align: bottom ; \">Date<\/td>\n<td style=\"max-width:79%; width:79%; min-width:79%;;vertical-align: bottom ; \">Friday, November 8, 2024<\/td>\n<td style=\"max-width:1%; width:1%; min-width:1%;;vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Time<\/td>\n<td style=\"vertical-align: bottom ; \">8:00 a.m. ET<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Toll free (U.S.)<\/td>\n<td style=\"vertical-align: bottom ; \">800-445-7795<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Conference ID<\/td>\n<td style=\"vertical-align: bottom ; \">4757982<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">Webcast (live and replay)<\/td>\n<td style=\"vertical-align: bottom ; \"><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=evmcsCYxdPZLvJGopSRvIF21sZ4I19yp-YUqZzGWp6c05kCBDlNK2RUfNaqooeGVTg_7b7LFNHA7grMMY4L6KzcHoRwjACaVFlxe24_ziToJ7Ui-b8QQIXbvo7V6n9RS\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>www.anipharmaceuticals.com<\/u><\/a>, under the \u201cInvestors\u201d section<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<td style=\"vertical-align: bottom ; \">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>A replay of the conference call will be available within two hours of the call\u2019s completion and will remain accessible for two weeks by dialing 800-839-8389 and entering access code 4757982.<\/p>\n<p><strong>About ANI Pharmaceuticals, Inc. <\/strong><\/p>\n<p align=\"justify\">ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of \u201cServing Patients, Improving Lives&#8221; by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&amp;D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=890m4jfUFrGA6NPwOiwn6Gmv3UoOI2YkgCPfet2e3tKxa8T9N_PtbtvgpNbhpGF799_1xTJ0hWvgp7Z0fDur6BK-io5t7lnN1VvP0l6eyZoC2pwHChR5YM_5jhPFvnJB\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.anipharmaceuticals.com\">www.anipharmaceuticals.com<\/a>.<\/p>\n<p align=\"justify\"><strong>Investor Relations Contact:<\/strong><br \/>Lisa M. Wilson, In-Site Communications, Inc.<br \/>212-452-2793<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ExUbcr8erBtMT3WcKPWpmDdE4dEtCAjVtbqOYssNuw4GZk958Xim_D1wWOK-LfhGkmMdioYMkXC5s7V-t_sJxEDB5jk6mhUoQLU-wYzDlIF7u44IEdGTIGt2yzPbJY2uBPqux3MZrdskGSS86ZiRkcu445SAfVhJPZPyCID1Ko3hVesttiL5Pe7F8ZC2up_pqsSUGY_EvFbHbLqQeTy3XaWErgu7bY3oWk2KzYS72bJBwPlElepD2SoII7ZVKMdx2EF7mjEhTPUAU4tcM4JVAQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"lwilson@insitecony.com\">lwilson@insitecony.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xyIV4IzhOfvT-0-yWH5J4z4iIS8XZ4YO9PLSFQCzuBRST7qYCEaCmJGXmOs1NjhFnGhsAHiHUB4McKgKsJCbtyCmXeBsEmkBGEbCv556nSutQddR3PjOPimbaORUTYLM_3_9egklNjT-mP1ni4vKGrIsLcpqsJwlvkpC_Mf4hWhvkzkzo1sFUlteqWCerd0YvFBiOer-CfNwSZkRxNuZ-AoOZdk8E7_zYjCeqPGMUvE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><br \/><\/a><\/p>\n<p><em>SOURCE: ANI Pharmaceuticals, Inc.<\/em><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWJmMGM2NGQtYTY2Yi00NjIzLWEzOWUtZGZlYmI4MGNiNzVhLTEwMzA4MzM=\/tiny\/ANI-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and [&#8230;]\n","protected":false},"author":1,"featured_media":61156,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-31T00:04:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/ANI-Pharmaceuticals-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET\",\"datePublished\":\"2024-10-31T00:04:58+00:00\",\"dateModified\":\"2024-10-31T00:04:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\"},\"wordCount\":249,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\",\"name\":\"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-10-31T00:04:58+00:00\",\"dateModified\":\"2024-10-31T00:04:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/","og_locale":"en_US","og_type":"article","og_title":"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET","og_description":"PRINCETON, N.J., Oct. 30, 2024 (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (NASDAQ: ANIP) today announced that","og_url":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-10-31T00:04:58+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/10\/ANI-Pharmaceuticals-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET","datePublished":"2024-10-31T00:04:58+00:00","dateModified":"2024-10-31T00:04:58+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/"},"wordCount":249,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/","url":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/","name":"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-10-31T00:04:58+00:00","dateModified":"2024-10-31T00:04:58+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/ani-pharmaceuticals-to-discuss-third-quarter-2024-financial-results-on-november-8-2024-at-800-a-m-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61155"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61155\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61156"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}